טוען...
KRAS Mutation: Comparison of Testing Methods and Tissue Sampling Techniques in Colon Cancer
Treatment of colon carcinoma with the anti-epidermal growth factor receptor antibody Cetuximab is reported to be ineffective in KRAS-mutant tumors. Mutation testing techniques have therefore become an urgent concern. We have compared three methods for detecting KRAS mutations in 59 cases of colon ca...
שמור ב:
| Main Authors: | , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Investigative Pathology
2010
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2797717/ https://ncbi.nlm.nih.gov/pubmed/20007845 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2353/jmoldx.2010.080131 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|